Today is July 01, 2024. All times in Eastern Daylight Time.
New Blood Test Predicts Recurrence of Breast Cancer, Months or Even Years Before Relapse
06/02/2024 - 06:00 PM
BUSINESS WIRE
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
06/02/2024 - 05:30 PM
BUSINESS WIRE
TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial
06/02/2024 - 02:32 PM
BUSINESS WIRE
CatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated with Visugromab/Nivolumab Combination
06/02/2024 - 12:30 PM
BUSINESS WIRE
Stronger Than Ever: Adani Portfolio Delivers Record Performance
06/02/2024 - 12:09 PM
BUSINESS WIRE
Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
06/02/2024 - 10:56 AM
BUSINESS WIRE
Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
06/02/2024 - 10:01 AM
BUSINESS WIRE
Tempus Introduces New HER2 & FOLR1 Testing Solutions to Support Personalized Patient Care
06/02/2024 - 09:30 AM
BUSINESS WIRE
ZT Systems Announces ACX200 Solutions Featuring NVIDIA GB200 Grace Blackwell Superchips for Next-Generation Accelerated Computing
06/02/2024 - 09:00 AM
BUSINESS WIRE
Denodo Integrates NVIDIA NIM Inference Microservices to Accelerate and Optimize AI Capabilities for Enterprises
06/02/2024 - 08:30 AM
BUSINESS WIRE
1
...
1347
1348
1349
1350
1351
1352
1353
1354
1355
1356
1357
« Previous
Next »